BIOEMTECH had the opportunity to attend this year’s AACR Annual Meeting, one of the most influential gatherings in cancer research worldwide.
AACR continues to set the tone for emerging trends in oncology, with strong momentum around radiopharmaceuticals, targeted therapies and translational approaches bridging preclinical and clinical research.
For us, it was a valuable chance to stay closely aligned with the evolving landscape, exchange insights with the scientific community and further understand how our technologies can support the next generation of discoveries.